809 A specific marker of oxidative protein modifications, 2,4-dinitrophenylhydrazine, labels the neurofibrillary pathology of Alzheimer disease

Mark A. Smith; Larry Sayre; Valerie C. Anderson; Peggy L. Richey; S. Siedlak; M. Flint Beal; Neil W. Kowall; George Perry

doi:10.1016/s0197-4580(96)80811-6

Back

809 A specific marker of oxidative protein modifications, 2,4-dinitrophenylhydrazine, labels the neurofibrillary pathology of Alzheimer disease

Article 1996 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1998

Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

Mark A. Smith, Lawrence M. Sayre, Vernon Anderson, Peggy L.R. Harris, M. Flint Beal, Neil W. Kowall, George Perry

Article1995

Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease

Mark A. Smith, Maria Rudnicka‐Nawrot, Peggy L. Richey, Darja Praprotnik, Paul Mulvihill, Carol A. Miller, Lawrence M. Sayre, George Perry

Article1990

Immunochemical demonstration of tropomyosin in the neurofibrillary pathology of Alzheimer's disease.

Pamela G. Galloway, Paul Mulvihill, Sandra L. Siedlak, Magdalena Mijares, Mitsuru Kawai, H Padget, R Kim, George Perry

Article1996

Elastase is associated with the neurofibrillary pathology of Alzheimer disease: a putative link between proteolytic imbalance and oxidative stress

Mark A. Smith, Peggy L. Richey, Rajesh N. Kalaria, George Perry

Article2008

Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.

Akanksha Thakur, Sandra L. Siedlak, Sheronica L James, David Bonda, Akanksha Rao, Kate M. Webber, Antoni Camins, Mercè Pallàs, Gemma Casadesús, Hyoung‐gon Lee, Robert Bowser, Arun K. Raina, George Perry, Mark A. Smith, Xiongwei Zhu